Nemo-Like Kinase (NLK) Is a Pathological Signaling Effector in the Mouse Heart
Ruijie Liu(Grand Valley State University), Jeffery D. Molkentin(Cincinnati Children's Hospital Medical Center)
Cited by 8
Related Papers
Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
|Journal of Clinical Investigation|2017|901
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
|Nature Communications|2016|897
Signaling effectors underlying pathologic growth and remodeling of the heart
|Journal of Clinical Investigation|2013|440
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
|Journal of Clinical Investigation|2010|438
Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling
|Journal of Clinical Investigation|2003|306